| [1] |
陈柳莹, 陆伦根. 重视慢性肝病的病情评估. 实用肝脏病杂志, 2017, 20:4-6.
|
| [2] |
Bedossa P. Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: why liver biopsy is essential. Liver Int, 2018, 38:64-66.
|
| [3] |
李进. 肝病诊疗指南. 北京:军事医学科学出版社, 2012:35-37.
|
| [4] |
张鸿飞, 董漪, 王丽旻, 等. 儿童肝穿刺组织病理与临床诊断3932例回顾性研究. 中华儿科杂志, 2014, 52:570-574.
|
| [5] |
张媛媛, 张国艳, 张黎明, 等. 肝脏活组织病理检查在非病毒性肝病诊断中的临床意义. 中华消化杂志, 2017, 37:756-760.
|
| [6] |
Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 2016, 64:73-84.
|
| [7] |
Boursier J, Mueller O, Barret M, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology, 2016, 63:764-775.
|
| [8] |
Watanabe S, Hashimoto E, Ikejima K, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. J Gastroenterol, 2015, 50:364-377.
|
